<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1415480D-B2DF-420B-8A8C-A5EF8452A1B1"><gtr:id>1415480D-B2DF-420B-8A8C-A5EF8452A1B1</gtr:id><gtr:firstName>Katarina</gtr:firstName><gtr:surname>Le Blanc</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/817C64CB-5196-4AC2-9C4D-5FFBD2B7BD0B"><gtr:id>817C64CB-5196-4AC2-9C4D-5FFBD2B7BD0B</gtr:id><gtr:firstName>Lindsay Catrina</gtr:firstName><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4FCCA34F-13FF-434C-8643-073AE49EC5DE"><gtr:id>4FCCA34F-13FF-434C-8643-073AE49EC5DE</gtr:id><gtr:firstName>Phil</gtr:firstName><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901562"><gtr:id>1B424080-2E43-43F9-AAF3-1A897C3F388A</gtr:id><gtr:title>Oral mucosal lamina propria progenitor cells as a novel and preferential source for treatment of Graft Vs Host Disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901562</gtr:grantReference><gtr:abstractText>Graft-Versus-Host-Disease (GVHD) is characterised by a direct attack on the patient?s body by immune cells present within transplanted donor blood stem cells. This disease is a major barrier to transplantation in that it leads to a high death rate. Bone marrow stem cells (BMSCs) can suppress this attack on the patient and reduce the incidence/severity of GVHD but there are problems with using these cells. We have identified within the mouth a novel population of progenitor (stem-like) cells (oral PCs) which are powerful suppressors of immune responses and are more effective than BMSCs, possibly due to something they secrete. This research will investigate in depth how these cells are able to exert their superior suppression on immune cells and how they are different to BMSCs. We will also utilise cutting edge technologies to identify what the soluble factors are so that these cells/factors can ultimately be utilised to help patients. Importantly, oral PCs have distinct advantages for therapeutic applications in that they come from an area of the mouth that is easily accessible and which will heal rapidly with no/minimal resultant scar formation for the patient. We believe that the increased potential of these oral PCs will make them a favoured source of cells for transplantation with blood stem cells in the treatment of GVHD and potentially a number of other diseases where the immune response is dysfunctional.</gtr:abstractText><gtr:technicalSummary>Mortality due directly to chronic GVHD remains one of the major obstacles in allogeneic haematopoietic stem cell (HSC) transplantation. Research suggests that co-transplantation of mesenchymal stem cells (MSCs) during HSC transplantation results in a significant decrease in acute and chronic GVHD. However, MSC heterogeneity means that trial results are variable and also large cell numbers are required to deliver an immunosuppressive effect which can sometimes initiate an immune response. We have recently demonstrated the existence of a novel, neural crest-derived PC population resident within the lamina propria of the oral mucosa which have a unique immunomodulatory capacity. These clonally-derived oral mucosal lamina propria-progenitor cells (OMLP-PCs) have the ability to lower lymphocyte proliferation back to base levels in the presence of alloantigens, in a contact-independent manner and at ratios as low as 0.001% of OMLP-PCs to allogeneic lymphocytes (levels much lower than for MSCs). This suggests that OMLP-PCs may work via a different mechanism(s) to MSCs and would be potentially more potent/effective than MSCs in the treatment of GVHD. This application will complete the in vitro characterisation of the immunosuppressive potential of OMLP-PCs in direct comparison to MSCs and identify the soluble factors involved in this response. Ultimately this project is aimed at translating our basic research findings into innovative and improved pre-clinical developments for the treatment of GVHD.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-15</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>387951</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>KI collaboration</gtr:description><gtr:id>BCD45CC9-AFC9-4B50-94D6-4202E61C96D3</gtr:id><gtr:impact>Stem Cell Dev 2012 paper published</gtr:impact><gtr:partnerContribution>Access to technical expertise, clinical insight into disease.</gtr:partnerContribution><gtr:piContribution>Sharing lab equipment, scientific expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit (Cardiff)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>98ADDCA4-3BA3-4307-8290-EA6AC31C79DC</gtr:id><gtr:impact>90 Year 5 pupils (3x 30) attended a hands on workshop (three stations - cell modelling, maggot racing, life sized operation game) on tissue engineering. Lots of discussion about science and potential career routes/prospects.

We have been invited back to present to other years. Twitter posts. This was number five of a whole series of planned visits to Schools in Cardiff.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture at Stem Cell Research Day (Cardiff University)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FAE1DC49-5B3D-4A44-AE26-6B61BF8D7A78</gtr:id><gtr:impact>Approximately 80 people (clinical and non-clinical) attended an internal workshop on stem cell research with Cardiff to gain an insight into each others research areas/expertise and to set up a network for future coordinated grant applications.

Circulation of relevant information around the network, establishment of peer-to-peer support.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9FFA8097-F739-447C-A131-10D814DB4F5E</gtr:id><gtr:impact>Public lecture for the Welsh Livery Guild on stem cells and the clinical potential for our ageing bodies</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Lecture - Mesenchymal Stem Cell Biology Course, Karolinska Institutet, Stockholm, Sweden 20th March 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>757108FE-4B7B-4E34-BC2E-5045629E702E</gtr:id><gtr:impact>Invited lecture with discussion afterwards

Developed research collaborations</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Lecture - Swansea University, Swansea, UK 11th April 2013 &quot;Oral Progenitor Cells - a Novel Therapy for the Treatment of Immune-Related Disorders?&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B6C11338-1D20-4AF3-9C58-14CCEF21C9A2</gtr:id><gtr:impact>Invited talk and discussion afterwards

Developed research collaborations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Co-hosted the first every European Tissue Repair Society Summer School (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>19E4312E-BC00-4986-AA27-F25BBD37681A</gtr:id><gtr:impact>A summer school to bring together about 20 postgraduate researchers from across Europe to learn, in an informal environment, about cutting edge advances in tissue repair and stem cells</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cell Meeting (Cardif)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>44E7F8CF-26A4-4924-9548-29FFDAAB13FA</gtr:id><gtr:impact>Approximately 70 people (clinical and non-clinical) attended an internal workshop on stem cell research with Cardiff to gain an insight into each others research areas/expertise and to set up a network for future coordinated grant applications.

Circulation of relevant information around the network, establishment of peer-to-peer support. An expansion of this meeting in 2013 to bring in other academic and industrial partners.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem Cell Research Day (2016)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>679D4FB7-7957-4F5F-94CA-898D48292BB6</gtr:id><gtr:impact>Approximately 140 people (clinical and non-clinical) attended an internal workshop on stem cell research with Cardiff to gain an insight into each others research areas/expertise and to set up a network for future coordinated grant applications.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Life Science Bridging Fund</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Government of Wales</gtr:fundingOrg><gtr:fundingRef>LSBF/R3-004</gtr:fundingRef><gtr:id>F0A1867C-B5A0-4B03-8F7F-7C6A214F9B06</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>92566</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cardiff University (School of Dentistry)/external PhD scheme</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Cardiff University</gtr:fundingOrg><gtr:id>61B27BD4-2881-4C9F-8538-FD0F2BB25315</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Confidence in Concept Scheme</gtr:department><gtr:description>Confidence in Concept Award</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1DF35F4E-B418-46C0-BC79-8C559A14E652</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Isolation and characterisation of progenitor cells from the oral (buccal) mucosa</gtr:description><gtr:id>3784E9EA-3455-4478-82B3-C0E9694EA391</gtr:id><gtr:impact>Not as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>2009249053 - Australia</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Oral Mucosal Stem Cells</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Isolation, characterisation and use of Oral Mucosal Stem Cells.</gtr:description><gtr:id>8FB89867-284D-4234-A648-07469D1E86D0</gtr:id><gtr:impact>-</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>JP5755138 - Japan</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Oral Mucosal Stem Cells</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Isolation and characterisation of progenitor cells isolated from the oral (buccal) mucosa</gtr:description><gtr:id>E8055D65-ACE9-4AB5-9F94-C2E814E4BD5C</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>09761964.7 (EP 2296674) - Europe</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Oral Mucosal Stem Cells</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Isolation, characterisation and use of Oral Mucosal Stem Cells.</gtr:description><gtr:id>9330F4E1-3D67-4E29-AC95-57DC17BBA9CC</gtr:id><gtr:impact>-</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>CN102089424B - China</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Oral Mucosal Stem Cells</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96C97961-AF21-4FCA-8111-033AE385BA3B"><gtr:id>96C97961-AF21-4FCA-8111-033AE385BA3B</gtr:id><gtr:title>Oral mucosal progenitor cells are potently immunosuppressive in a dose-independent manner.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce716bbece2b12d0e5b8448799816a57"><gtr:id>ce716bbece2b12d0e5b8448799816a57</gtr:id><gtr:otherNames>Davies LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DF0A444-76FF-4E43-B590-B45257CA8D22"><gtr:id>7DF0A444-76FF-4E43-B590-B45257CA8D22</gtr:id><gtr:title>Oral mucosal progenitor cell clones resist in vitro myogenic differentiation.</gtr:title><gtr:parentPublicationTitle>Archives of oral biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7f2c6f995087ec26faabfbad3168a9e"><gtr:id>d7f2c6f995087ec26faabfbad3168a9e</gtr:id><gtr:otherNames>Locke M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-9969</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DAFA1AC-5C86-4B56-BEAF-EFBA8085A904"><gtr:id>3DAFA1AC-5C86-4B56-BEAF-EFBA8085A904</gtr:id><gtr:title>Integration-Free Reprogramming of Lamina Propria Progenitor Cells.</gtr:title><gtr:parentPublicationTitle>Journal of dental research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13b4a53371196cfb1e4b1260250aea52"><gtr:id>13b4a53371196cfb1e4b1260250aea52</gtr:id><gtr:otherNames>Howard-Jones RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-0345</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0F7E25C-0815-4D47-B30C-E978B08C6D31"><gtr:id>C0F7E25C-0815-4D47-B30C-E978B08C6D31</gtr:id><gtr:title>Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c372e22477ebe150fdbad792182eec65"><gtr:id>c372e22477ebe150fdbad792182eec65</gtr:id><gtr:otherNames>Board-Davies E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901562</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>